Proactive Risk-based Optimization & Notifications for Treatment & Outcomes in Head & Neck Cancer

Recruiting N/A Interventional Study
Oral Cancer , Oral Squamous Cell Carcinoma, Oral Cavity Cancer Head &Amp;Amp; Neck Squamous Cell Carcinoma Larynx Squamous Cell Carcinoma
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Health Services Research
Participants needed
85 (estimated)
Sponsor
Centre hospitalier de l'Université de Montréal (CHUM) · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial
Delays between surgery and the initiation of post-operative radiotherapy (S-PORT) in head and neck cancer (HNC) patients are prevalent and associated with worse oncologic outcomes. This pilot study evaluates whether a proactive, automated care coordination system (PRONTO-HN) can improve adherence to recommended S-PORT intervals of ≤42 days at the Centre hospitalier de l'Université de Montréal (CHU…
Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * All adult patients (age 18 or older). * Pathologically confirmed oral cavity or laryngeal squamous cell carcinoma. * Diagnosed from July 2024 to September 2026. * With planned primary intention surgical resection. * With or without adjuvant therapy. * Treated at the Centre Hos…
Contacts

Apostolos Christopoulos, MD, MSc

‭+1 (514) 625-7360‬

a.christopoulos@umontreal.ca

CONTACT

Gabriel S Dayan, MD

5147782303

gabriel.dayan@umontreal.ca

CONTACT